HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2399368Generated: October 31, 2026
Phosgene → 8-chlorodibenz[b,f][1,4]oxazepin-10(11H)carbonyl chloride
https://huagongshe.com/reaction/2399368
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Phosgene | HCID 6371 | — |
| Reactant | Triethylamine | HCID 8471 | — |
| Reactant | 8-Chloro-10,11-dihydrodibenzo[b,f][1,4]oxazepine | HCID 15229227 | — |
| Solvent | Toluene | HCID 1140 | — |
| Solvent | Diethyl Ether | HCID 3283 | — |
| Product | 8-chlorodibenz[b,f][1,4]oxazepin-10(11H)carbonyl chloride | HCID 14975983 | — |
Reaction Steps
8-Chlorodibenz[b,f][1,4]-oxazepine-10(11H)-carbonyl chloride is synthesized in the manner described in U.S. Pat. No. 3,534,019: Phosgene (13 g, 131.4 mmol) in toluene (45 g) is stirred for 2 hours at 5°-10° C. and then diethyl ether (70 g) is added. This is followed by the addition of a solution of 8-chloro-10,11-dihydrodibenz[b,f][1,4]oxazepine (18.9 g, 81.6 mmol), prepared in the manner described in Example 1, and triethylamine (7.2 g, 9.92 mL, 71.2 mmol) in diethyl ether (140 g). After the addition is complete, the mixture is stirred for 2 hours, and then is filtered. The solvent is then evaporated from the filtrate, and the resulting residue is recrystallized from hexane, giving 8-chlorodibenz[b,f][1,41oxazepine-10(11H)-carbonyl chloride.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05449674 |
|---|
| Source dataset | uspto-grants-1995_09 |
|---|
| ORD ID | ord-2d18b65645ab4f1a922cb13c4cde4341 |
|---|
| Source note | uspto-grants-1995_09 |
|---|